Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 1 44-1, 1998, Pages

  Stockelman, Michael G ^a   Lorenz, John N ^a   Smith, Frost N ^a   Boivin, Gregory P ^a   Sahota, Amrik ^b   Tischfield, Jay A ^b   Stambrook, Peter J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Allopurinol; Chronic kidney failure; Kidney calculi; Purine metabolism; Sex factors

Indexed keywords

2,8 DIHYDROXYADENINE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ALLOPURINOL; XANTHINE DEHYDROGENASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CREATININE CLEARANCE; ENZYME DEFICIENCY; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE; KIDNEY INTERSTITIUM; MALE; MORPHOMETRICS; MOUSE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

EID: 0031815813     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.1.f154     Document Type: Article

References (40)

1. Abuelo, J. G. Renal Pathophysiology: The Essentials (1st ed.). Baltimore, MD: Williams and Wilkins, 1989, p. 322.
2. Ansari, N. H., and S. Rajaraman. Allopurinol-induced nephrotoxicity: protection by the antioxidant, butylated hydroxytoluene. Res. Commun. Chem. Pathol. Pharmacol. 75: 221-229, 1992.
3. Bartlett, G. R. Metabolism by man of intravenously administered adenine. Transfusion 17: 367-373, 1977.
4. Bartlett, G. R. Metabolism by the rabbit of intravenously administered adenine. Transfusion 17: 351-357, 1977.
5. Broderick, T. P., D. A. Schaff, A. M. Bertino, M. K. Dush, J. A. Tischfield, and P. J. Stambrook. Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement. Proc. Natl. Acad. Sci. USA 84: 3349-3353, 1987.
6. Cameron, J. S., H. A. Simmonds, A. Cadenhead, and D. Farebrother. Metabolism of intravenous adenine in the pig. Adv. Exp. Med. Biol. 76A: 196-205, 1977.
7. Cotran, R. S., V. Kumar, and S. L. Robbins. Robbins' Pathological Basis of Disease. Philadelphia, PA: Saunders, 1989.
8. De Vries, A., and O. Sperling. Implications of disorders of purine metabolism for the kidney and the urinary tract. Ciba Found. Symp. 48: 179-206, 1977.
9. Elion, G. B. Enzymatic and metabolic studies with allopurinol. Ann. Rheum. Dis. 25: 608-614, 1966.
10. Elion, G. B., F. M. Benezra, I. Canellas, L. O. Carrington, and G. H. Hitchings. Effects of xanthine oxidase inhibitors on purine catabolism. Israel J. Chem. 6: 787-796, 1968.
11. Elion, G. B., A. Kovensky, and G. H. Hitchings. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem. Pharmacol. 15: 863-880, 1966.
12. Engle, S. J., M. G. Stockelman, J. Chen, G. Boivin, M.-N. Yum, P. M. Davies, M. Y. Ying, A. Sahota, H. A. Simmonds, P. J. Stambrook, and J. A. Tischfield. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. USA 93: 5307-5312, 1996.
13. Folin, O., and H. Wu. A system of blood analysis. J. Biol. Chem. 38: 81-110, 1919.
14. Frayha, R. A. Allopurinol. A review. Lebanese Med. J. 24: 463-71, 1971.
15. Gault, M. H., L. Chafe, P. Parfrey, and W. G. Robertson. The kidney-ureter stone sexual paradox: a possible explanation. J. Urol. 141: 1104-1106, 1989.
16. Goldstone, A., H. Koenig, and C. Lu. Testosterone-dependent sexual dimorphism of the mouse kidney is mediated by polyamines. Biochem. Biophys. Res. Commun. 104: 165-172, 1982.
17. Greenwood, M. C., M. J. Dillon, H. A. Simmonds, T. M. Barratt, J. R. Pincott, and C. Metreweli. Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur. J. Pediatr. 138: 346-349, 1982.
18. Henderson, J. F., G. Zombor, M. M. Johnson, and C. M. Smith. Variation in erythrocyte purine metabolism among mouse strains. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 76: 419-422, 1983.
19. Huh, K., I. Yamamoto, E. Gohda, and H. Iwata. Tissue distribution and characteristics of xanthine oxidase and allopurinol oxidizing enzyme. Jpn. J. Pharmacol. 26: 719-724, 1976.
20. Humason, G. L. Animal Tissue Techniques. San Francisco, CA: Freeman, 1979.
21. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. Simplified mammalian DNA isolation procedure (Abstract). Nucleic Acids Res. 19: 4293, 1991.
22. Lee, P. C. Developmental changes of adenosine deaminase, xanthine oxidase, and uricase in mouse tissues. Dev. Biol. 31: 227-233, 1973.
23. Lindblad, G., G. Jonsson, and J. Falk. Adenine toxicity: a three week intravenous study in dogs. Acta Pharmacol. Toxicol. 32: 246-256, 1973.
24. McAnulty, P. A., and J. P. Williams. Polyamines and their biosynthetic decarboxylases in various tissues of the young rat during recovery from undernutrition. Biochem. J. 162: 109-121, 1977.
25. Neish, W. J., and L. Key. Polyamines and glutathione in livers of normal rats of different ages and in livers of pregnant rats. Biochem. Pharmacol. 17: 497-502, 1968.
26. Olsen, N. V., S. D. Ladefoged, B. Feldt-Rasmussen, N. Fogh-Andersen, H. Jordening, and O. Munck. The effects of cimetidine on creatinine excretion, glomerular filtration rate and tubular function in renal transplant recipients. Scand. J. Clin. Lab. Invest. 49: 155-159, 1989.
27. Silbiger, S. R., and J. Neugarten. The impact of gender on the progression of chronic renal disease. Am. J. Kidney Dis. 25: 515-533, 1995.
28. Simmonds, H. A. 2,8-Dihydroxyadenine lithiasis. Clin. Chim. Acta 160: 103-108, 1986.
29. Simmonds, H. A., A. Sabota, and K. J. Van Acker. APRT deficiency: 2,8-dihydroxyadenine lithiasis. In: The Metabolic and Molecular Bases of Inherited Disease (7th ed.), edited by J. B. Stanbury, J. B. Wyngaarden, and D. G. Fredrickson. New York: McGraw-Hill, 1995.
30. Simmonds, H. A., K. J. Van Acker, J. S. Cameron, and A. McBurney. Purine excretion in complete adenine phosphoribosyltransferase deficiency: effect of diet and allopurinol therapy. Adv. Exp. Med. Biol. 76B: 304-311, 1977.
31. Suzuki, Y., and J. Sudo. Possible mechanism responsible for allopurinol-nephrotoxicity: lipid peroxidation and systems of producing- and scavenging oxygen radicals. Jpn. J. Pharmacol. 45: 271-279, 1987.
32. Tabor, H., and C. W. Tabor. Biosynthesis and metabolism of 1,4-diaminobutane, spermidine, spermine, and related amines. Adv. Enzymol. Relat. Areas Mol. Biol. 36: 203-268, 1972.
33. Trachtman, H., E. Valderrama, and S. Futterweit. Nephrotoxicity of allopurinol is enhanced in experimental hypertension. Hypertension 17: 194-202, 1991.
34. Wainer, L., V. A. Resnick, and M. I. Resnick. Nutritional aspects of stone disease. In: Renal Stone Disease: Pathogenesis, Prevention and Treatment, edited by C. Y. C. Pak. Boston, MA: Martinus Nijhoff, 1987, p. 85-120.
35. Watts, R. W. Molecular variation in relation to purine metabolism. J. Clin. Pathol., Suppl. 8: 48-63, 1974.
36. Wexler, B. C., and B. P. Greenberg. Allopurinol-induced myocardial and renal damage in nonarteriosclerotic (virgin) and arteriosclerotic (breeder) Sprague-Dawley rats. Proc. Soc. Exp. Biol. Med. 157: 541-549, 1978.
37. Williams-Ashman, H. G., A. E. Pegg, and D. H. Lockwood. Mechanisms and regulation of polyamine and putrescine biosynthesis in male genital glands and other tissues of mammals. Adv. Enzyme Regul. 7: 291-323, 1969.
38. Williams-Ashman, H. G., J. Seidenfeld, and P. Galletti. Trends in the biochemical pharmacology of 5′-deoxy-5′-methylthioadenosine. Biochem. Pharmacol. 31: 277-288, 1982.
39. Wu, X., M. Wakamiya, S. Vaishnav, R. Geske, C. Montgomery, Jr., P. Jones, A. Bradley, and C. T. Caskey. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc. Natl. Acad. Sci. USA 91: 742-746, 1994.
40. Wyngaarden, J. B., and J. T. Dunn. 8-hydroxyadenine as the metabolic intermediate in the oxidation of adenine to 2,8-dihydroxyadenine by xanthine oxidase. Arch. Biochem. Biophys. 70: 150-6, 1957.